Publications by authors named "Catherine Billups"

Claim this Profile
A
An integrated analysis of three medulloblastoma clinical trials refines risk-stratification approaches for reducing toxicity and improving survival.
Authors Kyle S Smith, Sandeep K Dhanda, Catherine A Billups, Edgar Sioson, Congyu Lu

Neuro Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterizing Sensitivity to Vincristine, Irinotecan, and Telomerase-targeted Therapy in Diffuse Anaplastic Wilms Tumor Patient-derived Xenografts.
Daniel B Gehle, Carolyn M Jablonowski, Prahalathan Pichavaram, Shivendra Singh, Mary A Woolard, Catherine A Billups

J Pediatr Surg· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isotretinoin has no effect on event-free survival across high-risk medulloblastoma molecular groups when added to maintenance: A secondary analysis of the Children's Oncology Group ACNS0332 data.
Scott Raskin, Peter de Blank, Catherine A Billups, Yimei Li, James M Olson

Neurooncol Adv· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Academic readiness among young children treated for brain tumors: a multisite, prospective, longitudinal trial.
Melanie R Somekh, Jason M Ashford, Michelle A Swain, Lana L Harder, Bonnie L Carlson-Green, Catherine A Billups

J Natl Cancer Inst· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA-methylation subgroups carry no prognostic significance in ATRT-SHH patients in clinical trial cohorts.
Quynh T Tran, Santhosh A Upadhyaya, Catherine A Billups, Arzu Onar-Thomas, Md Zahangir Alom

Acta Neuropathol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of alisertib as a single agent for treating recurrent or progressive atypical teratoid/rhabdoid tumor.
Santhosh A Upadhyaya, Olivia Campagne, Catherine A Billups, Brent A Orr, Arzu Onar-Thomas

Neuro Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Carboplatin and Isotretinoin in Children With High-risk Medulloblastoma: A Randomized Clinical Trial From the Children's Oncology Group.
Sarah E S Leary, Roger J Packer, Yimei Li, Catherine A Billups, Kyle S Smith

JAMA Oncol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Children's Oncology Group Phase III Trial of Reduced-Dose and Reduced-Volume Radiotherapy With Chemotherapy for Newly Diagnosed Average-Risk Medulloblastoma.
Jeff M Michalski, Anna J Janss, L Gilbert Vezina, Kyle S Smith, Catherine A Billups

J Clin Oncol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of Cognitive Performance Among Infants Treated for Brain Tumors: Findings From a Multisite, Prospective, Longitudinal Trial.
Jeanelle S Ali, Jason M Ashford, Michelle A Swain, Lana L Harder, Bonnie L Carlson-Green, Catherine A Billups

J Clin Oncol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relevance of Molecular Groups in Children with Newly Diagnosed Atypical Teratoid Rhabdoid Tumor: Results from Prospective St. Jude Multi-institutional Trials.
Santhosh A Upadhyaya, Giles W Robinson, Arzu Onar-Thomas, Brent A Orr, Pascal Johann, Catherine A Billups

Clin Cancer Res· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed Medulloblastoma.
Rahul Kumar, Kyle S Smith, Maximilian Deng, Colt Terhune, Giles W Robinson, Catherine A Billups

J Clin Oncol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of peginterferon alpha-2b for patients with unresectable or recurrent craniopharyngiomas: a Pediatric Brain Tumor Consortium report.
Stewart Goldman, Ian F Pollack, Regina I Jakacki, Catherine A Billups, Tina Y Poussaint

Neuro Oncol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I/II study of veliparib (ABT-888) with radiation and temozolomide in newly diagnosed diffuse pontine glioma: a Pediatric Brain Tumor Consortium study.
Patricia A Baxter, Jack M Su, Arzu Onar-Thomas, Catherine A Billups, Xiao-Nan Li

Neuro Oncol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II Study of Nonmetastatic Desmoplastic Medulloblastoma in Children Younger Than 4 Years of Age: A Report of the Children's Oncology Group (ACNS1221).
Lucie Lafay-Cousin, Eric Bouffet, Douglas Strother, Vasilisa Rudneva, Cynthia Hawkins, Catherine A Billups

J Clin Oncol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Forty-five patient-derived xenografts capture the clinical and biological heterogeneity of Wilms tumor.
Andrew J Murphy, Xiang Chen, Emilia M Pinto, Justin S Williams, Michael R Clay, Catherine A Billups

Nat Commun· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular grouping and outcomes of young children with newly diagnosed ependymoma treated on the multi-institutional SJYC07 trial.
Santhosh A Upadhyaya, Giles W Robinson, Arzu Onar-Thomas, Brent A Orr, Catherine A Billups

Neuro Oncol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical activity of the antibody-drug conjugate denintuzumab mafodotin (SGN-CD19A) against pediatric acute lymphoblastic leukemia xenografts.
Luke Jones, Hannah McCalmont, Kathryn Evans, Chelsea Mayoh, Raushan T Kurmasheva, Catherine A Billups

Pediatr Blood Cancer· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extensive Molecular and Clinical Heterogeneity in Patients With Histologically Diagnosed CNS-PNET Treated as a Single Entity: A Report From the Children's Oncology Group Randomized ACNS0332 Trial.
Eugene I Hwang, Marcel Kool, Peter C Burger, David Capper, Lukas Chavez, Catherine Billups

J Clin Oncol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-Related Quality of Life and Survival Outcomes of Pediatric Patients With Nonmetastatic Osteosarcoma Treated in Countries With Different Resources.
Michael W Bishop, Shailesh M Advani, Milena Villarroel, Catherine A Billups, Fariba Navid

J Glob Oncol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurologic impairments from pediatric low-grade glioma by tumor location and timing of diagnosis.
Zsila S Sadighi, Elizabeth Curtis, Jennifer Zabrowksi, Catherine Billups, Amar Gajjar

Pediatr Blood Cancer· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial.
Giles W Robinson, Vasilisa A Rudneva, Ivo Buchhalter, Catherine A Billups, Sebastian M Waszak

Lancet Oncol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prior non-irradiative focal therapies do not compromise the efficacy of delayed episcleral plaque brachytherapy in retinoblastoma.
John T Lucas, Rose McGee, Catherine A Billups, Ibrahim Qaddoumi, Thomas E Merchant

Br J Ophthalmol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
F-FDG Uptake During Early Adjuvant Chemotherapy Predicts Histologic Response in Pediatric and Young Adult Patients with Osteosarcoma.
James C Davis, Najat C Daw, Fariba Navid, Catherine A Billups, Jianrong Wu

J Nucl Med· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II trial evaluating the feasibility of adding bevacizumab to standard osteosarcoma therapy.
Fariba Navid, Victor M Santana, Michael Neel, M Beth McCarville, Barry L Shulkin, Catherine A Billups

Int J Cancer· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioluminescence Imaging Enhances Analysis of Drug Responses in a Patient-Derived Xenograft Model of Pediatric ALL.
Luke Jones, Jennifer Richmond, Kathryn Evans, Hernan Carol, Duohui Jing, Catherine A Billups

Clin Cancer Res· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis